Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
+251K
-
Total reported value, excl. options
-
$38.5M
-
Value change
-
+$1.84M
-
Put/Call ratio
-
1
-
Number of buys
-
28
-
Number of sells
-
-16
-
Price
-
$3.80
Significant Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q4 2017
56 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - COMMON STOCK as of Q4 2017.
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
.
Largest 10 shareholders include Vanguard Group Inc (2.41M shares), Wildcat Capital Management, LLC (1.74M shares), Intellectus Partners, LLC (1.53M shares), MILLENNIUM MANAGEMENT LLC (1.26M shares), BlackRock Inc. (968K shares), GEODE CAPITAL MANAGEMENT, LLC (461K shares), OxFORD Asset Management LLP (216K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (169K shares), BANK OF AMERICA CORP /DE/ (145K shares), and NORTHERN TRUST CORP (135K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.